← Back to Clinical Trials
Recruiting NCT07041502

NCT07041502 Aut-CARE Intervention to Improve Cognitive and Emotional Functioning in Young Adults on the Autism Spectrum

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07041502
Status Recruiting
Phase
Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition Autism Spectrum Disorder
Study Type OBSERVATIONAL
Enrollment 37 participants
Start Date 2024-10-16
Primary Completion 2026-09-15

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 30 Years
Study Type OBSERVATIONAL
Interventions
Aut-CARE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 37 participants in total. It began in 2024-10-16 with a primary completion date of 2026-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Currently, many autistic youths struggle to adapt to academic programs or the workforce, often turning to third-sector organizations such as specialized associations and foundations. This may be due to factors such as emotional dysregulation and executive dysfunction, which interfere with their psychosocial adaptation abilities, leading to anxiety and depression. These challenges have a neurobiological basis tied to the unique complexities of the autistic brain, which experiences emotional and cognitive overload and lacks attentional filters. To address this issue, the emotional and executive functioning of autistic youths at the Friends Foundation will be assessed through objective and subjective assessments. This data collection will serve as a foundation for conceptualizing and co-creating a more realistic affective-cognitive remediation program, integrating user perspectives (conceptualization of interventions for systematic implementation). The program aims to improve the socio-occupational and emotional adaptation difficulties that often contribute to mental health challenges within this underserved population. It is important to highlight that many existing programs focus on cognitive training and social skills, neglecting strategies for adaptation and emotional regulation. This project will stand out for its inclusive design, featuring a representative sample of both sexes, overcoming the usual limitation of male-centered approaches.

Eligibility Criteria

Inclusion Criteria: * Subjects aged 16 to 30 years (male, female, and non-binary) * Attending one or more services of the Friends Foundation (Prelaboral Friends, Laboral Friends, and EducaFriends). * Diagnosed with ASD (according to DSM-5 criteria), levels 1 or 2, and without intellectual disability (IQ \> 80). Exclusion Criteria: * None

Contact & Investigator

Central Contact

Alejandra Espinosa

✉ AEspinosaG@santpau.cat

📞 +34 93 553 78 13

Frequently Asked Questions

Who can join the NCT07041502 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 30 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07041502 currently recruiting?

Yes, NCT07041502 is actively recruiting participants. Contact the research team at AEspinosaG@santpau.cat for enrollment information.

Where is the NCT07041502 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT07041502 clinical trial?

NCT07041502 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 37 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology